FDA’s Office of Health Informatics is excited to announce that precisionFDA, a secure cloud-based collaborative platform for advancing regulatory science though analysis of large biological datasets, has won a 2019 FedHealthIT Innovation award. PrecisionFDA was nominated and selected for this award from a group of peers. Investigators can use precisionFDA to host and collaborate on large datasets using multi-omics technology. To learn more about the platform, and how it might support your work, visit: https://go.usa.gov/xmMuU.
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...